• Additional Information

    Additional Information

     

Events

Planned conferences / workshops / meetings as well as scientific contributions / publications

For the latest information see below and Join in!

 

February 2022

  • DKF Tag der Klinischen Forschung, Universitätsspital Basel, 10.2.2022
Abstract/Poster:
ENGOT-ov54/Swiss-GO-2/MATAO: MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer - A Swiss investigator initiated RCT on re-purposing of a generic drug.
Presenter: Pamela McLaughlin

Actual: Annemarie Karrasch Forschungspreis: Preisverleihung 2022 Prof. Dr. Viola Heinzelmann-Schwarz

 March 2022

  • MATAO CH-D-A Investigator (PI) Meeting, Basel 5.03 - 06.03.2022 (virtual)
  • SAKK In-between Meeting I: 10.03.2022, 16.00-18.00h (virtual)

 April 2022

  • AACR Annual Meeting, 8.4.-13.4.2022 (New Orleans, USA), Abstract submission closed / None submitted
  • Spring ENGOT General Assembly: April 28-29, 2022 - Hotel Marriott, Copenhagen, Denmark

May 2022

  • SAKK Semi-Annual Meeting: 05.05.–06.05.2022 in Zurich (final decision not before 05.03.22)

June 2022

  • Swiss-GO General Member assembly (planed for begiining of June 2022)
  • ASCO Annual Meeting 2022, 3.6-7.6.2022 (Chicago, USA), Abstract submission deadline: 15.02.2022
  • SGGG Jahresversammlung, 23.6.-25.6.2022 (St.Gallen), Abstract-Einreichungsfrist: 10.02.2022 (17 Uhr)
Actual Episode with Prof. Viola Heinzelmann in the Podcast Series  "Wissen gegen Krebs" of Krebsforschung Schweiz: "Unabhängige Forschung – der Schlüssel zu Innovation"
 

July 2022

August 2022

September 2022

  • SAKK In-between Meeting II: 22.09.2022, 16.00-18.00h (virtuall)

October 2022

  • Autumn ENGOT General Assembly: October 6-7, 2022 - Hotel H10 Ku´Damm, Berlin, Germany
  • DGGG, 64. Jahresversammlung, 12.10.-15.10.2022 (München), Abstract-Einreichungsfrist: 15.05.2022

November 2022

  • SAKK : Semi-Annual Meeting I 16.11.2022,Congress Center Basel, Messeplatz 21, 4058 Basel, 13.30-17h

December 2022

  •  Swiss-GO Executive Board Meneber meeting 02. 12.2022, virtual  (Monday, 19pm)

Planned for 2023

SAKK: In-between I: 2.03.23, 9.00-11.00 (virtual)

ENGOT General Assembly: March 9-10, 2023 - Madrid, Spain

SAKK: Semi-Annual Meeting I: 12.05.23, 8.30-12.00 (Bern)

SAKK: In-between II: 28.09.23, 9.00-11.00 (virtual)

Planned conferences / workshops / meetings as well as scientific contributions Year 2021 (Status 31.01.2022)

Conferences:

  • Festival of Biologics:   World Clinical Trials Congress Basel 2022  November 2nd, 2022 

       Panel discussion : "Panel Discussion: How has the pandemic redefined decentralized clinical trials?" 

Speakers: Pamela Mclaughlin, Clinical Trial Manager at Swiss GO Trial Group and Clinical Chemist,University Hospital Basel, Laura Galuchie,Sr Director, Global Trial Management, MSD and Benoit Marchal, Project Manager, Partners for patients

  •  ASCO Annual Meeting 2021, 4.6.-8.6.2021 (Chicago, USA)

Abstract/Poster:

ENGOT-ov54/Swiss-GO-2/MATAO including LOGOS (Low Grade Ovarian cancer Sub-study): MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer; a randomized, double-blinded, placebo-controlled, multi-center phase III Trial

Viola A. Heinzelmann-Schwarz, Christian Kurzeder, Seraina Schmid, Natalie Gabriel, Andreas Mueller, Mathias K. Fehr, Christian Marth, Andreas Du Bois, Maximillian Klar

  • ASCO Annual Meeting 2021, 4.6.-8.6.2021 (Chicago, USA)
Abstract/Poster:
Health concerns in long-term survivors with ovarian cancer: Results of Expression VI–Carolin meets HANNA–Holistic Analysis of Long-term survival with Ovarian Cancer—The international NOGGO, ENGOT and GCIG survey

Hannah Woopen, Maren Keller, Ioana Braicu, Dario Zocholl, Joanna Baum, Petra Krabisch, Tamara Boxler, Pauline Wimberger, Catarina Madroñal, Marta Gil-Martin, Vesna Bjelic-Radisic, Sinisha Trpchevski, Eleftherios Pierre Samartzis, Viola A. Heinzelmann-Schwarz, Patriciu Achimaș-Cadariu, Paul Kubelac, Mehmet Ali Vardar, Marcin Andrzej Jedryka, Ignace Vergote, Jalid Sehouli

  • ENGOT Meeting 2021, 30.9-1.10. 2021 (Kopenhagen, DK)
Abstract:
ENGOT-ov54/Swiss-GO-2/MATAO including LOGOS (Low Grade Ovarian cancer Sub-study): MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer; a randomized, double-blinded, placebo-controlled, multi-center phase III Trial
Viola A. Heinzelmann-Schwarz, Christian Kurzeder, Seraina Schmid, Natalie Gabriel, Andreas Mueller, Mathias K. Fehr, Christian Marth, Andreas Du Bois, Maximillian Klar
  • GCIG Autumn Meeting 2021, 8.11.-19.11.2021 (virtual)
Abstract:
ENGOT-ov54/Swiss-GO-2/MATAO including LOGOS (Low Grade Ovarian cancer Sub-study): MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer; a randomized, double-blinded, placebo-controlled, multi-center phase III Trial
Viola A. Heinzelmann-Schwarz, Christian Kurzeder, Seraina Schmid, Natalie Gabriel, Andreas Mueller, Mathias K. Fehr, Christian Marth, Andreas Du Bois, Maximillian Klar

Address

Swiss GO Trial Group
Gynecological Oncology
Hospital for Women
University Hospital Basel
Spitalstrasse 21
CH-4031 Basel
Switzerland

Contact Info

Phone: +41 61 265 75 00
Fax:      +41 61 265 93 22

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Swiss GO Logo
© Swiss GO Trial Group, Basel